The novel immunosuppressive agent AEB071 is currently being evaluated for its capability to prevent rejection after kidney transplantation as a potential adjunct to calcineurin inhibitor-based regimen.
Domain | aeb071inhibitor.com |
---|---|
Homepage URL | https://aeb071inhibitor.com/enhancing-active-internet-sites-for-prime-company-selectivity-during-carbon-hydrogenation-more-than-supported-nickel-factors/ |
Keywords | aeb071 inhibitor cftr levulinic acid biological production |
Sprache | englisch |